Epigenetic marks can keep cancer cells susceptible to chemotherapy if they act like locks on gene expression. Unfortunately, when chemotherapy commences, the locks on cancer-favoring genes can pop open. According to a new study of chemotolerance in breast cancer, preventing H3K27me3 demethylation during chemotherapy inhibits the transition to a drug-tolerant state, and delays tumor recurrence in vivo.